ASSESSMENT OF THE SERUM LEVEL OF COMPLEMENT C3 AND C4 IN CHRONIC VIRAL HEPATITIS C INFECTION AND THEIR CORRELATION WITH RESPONSE TO DIRECT ACTING ANTI-VIRAL AGENTS

Serum soluble cluster of differentiation 163 (sCD163), matrix metalloproteinase 9 (MMP9) and cytokeratin 18 (CK18) levels as biomarkers for liver fibrosis in Egyptian chronic hep

SERUM MARKERS FOR ASSESSING LIVER FIBROSIS IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS B AND C CO-INFECTION VERSUS CHRONIC HEPATITIS C

Biochemical markers and physiological functions in Egyptian patients with hepatitis C virus

STUDY OF PENTRAXIN-3 LEVELS IN EGYPTIAN CIRRHOTIC PATIENTS

Role of Serum Interleukin–10 as a Marker of T-helper 2 Activity in Egyptian Chronic Hepatitis C Patients

Serum TNF-α levels as a biomarker in some liver diseases of Egyptian patients

Study of autoantibodies in Egyptian non-B,non-C chronic hepatitis patients

IL-1α and TGF-β1 as non-Invasive Liver Fibrosis Markers of Chronic Liver Injury among Chronic Liver Diseases Patients in Sharkia Governorate, Egypt

Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients